Member Info for Mafuta

We are making significant progress in bringing the company's CIZ1B test to market. CIZ1B is highly associated with early-stage lung cancer and after extensive and dedicated research at the University of York, we are now at a point where the test will be made available to clinicians and patients to help in the drive to detect cancer early and as a result save lives. A key step in making the test commercial is to partner with a trusted global manufacturer with the skills, experience and first-class quality-assured facilities to produce reliable, robust and reproducible antibodies.

LH&K Mafuta

Very positive comment from Mo:

"The outlook for hVIVO is positive as we welcomed our first volunteers into our new facility at Canary Wharf - the world's largest human challenge trial unit. I believe we have laid the foundations for strong performance in the months and years ahead."

What's not to like?

LH&K Mafuta

Great results ... I wonder what the EPS is? ... I guess we'll have to wait for the full set of figures for that ... LH&K Mafuta

Oracle - "very honoured to have you with us" or words to that effect ... Not sure if royalty or notoriety though ... LH&K Mafuta

Oops sorry ... I didn't realise some of you knew WIP on a personal level ... LH&K Mafuta

I wouldn’t be a bit surprised that there was some tricky business going on behind the scenes. The lack of positive response in the share price plus the stoking up of the “boiler room” seems to confirm this. WIP who was vert well informed (too well informed perhaps for his/her own comfort – hence the hasty disappearance0 used to remind us all what a cut-throat business we are in. There is nothing yet that convinces me to sell up and go (albeit at a profit) yes funding is an issue but the board has seen it has shareholder support if required, and they did respond to the e-mails re a subscription offer that some of us made on a personal level. My view? Hold and buy as and when funds allow, but that’s just my opinion. LH&K Mafuta

If calling out the looney tunes brigade means I have a superiority complex then so be it ... good to see you back DeAaar ... you taken a short out?

Quite a cacophony of them today ;0)

It's good to recognise its only the headline data that has been released ... So there will be more coming once the data set has been fully analysed and interpreted ... but what we do know is the results are good ... LH&K Mafuta

The only serious side effects of this RNS are the asinine comments posted by certain intellectually challenged ones.

"Together with the long half-life observed, we believe this potentially gives SDC-1801 significant advantages over its competitors." ... SIGNIFICANT ADVANTAGES ... Can't get better than that 👌👍LH&K Mafuta

Beef are you serious? You want to come on a chat room to ask for investment advice? ... It would be safer for you to put your money in a biscuit tin under your bed ... LH&K Mafuta

Has the herd arrived? 🐎🐎🐎

We seem to have people posting on this forum that know how to word regulatory news better than the NOMAD ... perhaps they should offer their services to the BOD .... 🙄

Due to a few more comments this morning I lower my estimate to 8 .... 🙄

As SOG mentions the data needs to be analysed and "sanitised" (Some of the data may well be commercially sensitive) ... the information will then need to be formulated in a suitable form for approval by the NOMAD .... all this takes time

I wonder what is the average age of those who post on this forum/ ... from some of the comments as of late I would estimate about 10? ;o}

Numerically challenged?🤣

Hi Both. i agree news is pivotal and it will come shortly ... I don't for one minute expect anything less than positive results, the trials would have been aborted long ago if there was any problem with the compound ... you just don't continue spending money on trials if there is no point in doing so ... we should be due a major re-valuation on receipt of the results ... then let the haggling take place ... best regards to you both ... Mafuta

The statement was: " ... topline data from the Phase 1a clinical trial are expected to be available during Q2 2024." .... Just basic English comprehension really ... "Expected to be available" not "will be published" or 'by the end of June" ... Even if the data is available it does not mean it will be in a state ready for publishing ... Who knows they may already have the raw data and are busy getting it in a state ready for the RNS ... for goodness sake people get a grip ... LH&K Mafuta